Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Natriruetic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant

NCT06416735 is registered in ClinicalTrials.gov with Ospedale San Raffaele as lead sponsor.

NCT NCT06416735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06416735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Natriruetic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant
Lead sponsor
Ospedale San Raffaele
Phase
Phase 3
Overall status
Completed
Start date
September 28, 2018
Completion date
July 20, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetic hypertension, hypertension essential, salt excess